The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries.
The William J Clinton Foundation (WJCF) is an Indian not-for-profit entity, registered under Section 8 of the Indian Companies Act 2013 and has an affiliation agreement with the Clinton Health Access Initiative (CHAI). WJCFs mission is to save lives and improve health outcomes in the country by enabling the government and private sector to strengthen and sustain quality health systems. WJCF has been working closely with the Ministry of Health & Family Welfare, and Departments of Health at the state level since 2007 providing technical as well as operational support to various programs such as COVID-19 disease, hepatitis, HIV/AIDS, tuberculosis, vector-borne diseases (lymphatic filariasis and kala azar), syphilis, cervical cancer, diabetes, maternal and childhood anaemia, immunization, under 5 diarrhea and pneumonia, sexual and reproductive health, Ayushman Bharat Pradhan Mantri – Jan Arogya Yojana (AB PM-JAY) and Ayushman Bharat Digital Mission (ABDM), hypoxemia and oxygen, safe drinking water, sickle cell disease, and climate and health.
Learn more about our exciting work: http://www.clintonhealthaccess.org
Program Overview:
Type 1 Diabetes Mellitus (T1D) is an auto-immune disease characterized by reduced ability to produce insulin in the body. T1D usually develops in children, adolescents, or young adults, leading to a lifetime dependence on insulin for survival. The condition is associated with a significant strain and poor quality of life, and leading to a high financial burden, for people living with Type 1 Diabetes (PLT1D) and their families. However, with access to timely diagnostic, initiation on treatment and proper management of the condition, people living with T1D can lead healthy and productive lives, while achieving life expectancy comparable to the general population.
There are an estimated 9.4 million PLT1D globally, with India having the second highest share accounting for 8%-10% of the global prevalence. Nearly 18% of children and adolescents with T1D (~0.3 million) live in India, the highest in the world. The incidence of T1D in the 0-19 age group is increasing more than any other age group and is estimated to increase from 8.15 per 100,000 in 2024 to 13.95 per 100,000 by 2040. While the burden of T1D has continued to rise over the years, survival has remained poor. Survival rates for children and adolescents with T1D in India is worse compared to countries with similar socio-economic development. On average, a child diagnosed with T1D at the age of 10 years lives only an additional 29 years of healthy life, contributing to premature mortality and poor quality of life.
There is an urgent need to improve access to screening and diagnosis and to ensure initiation and adherence to treatment for T1D. WJCF’s Type 1 Diabetes program aims at strengthening and improving access to quality T1D care in India, with the overall goal of achieving longer, healthier, and more productive lives for People Living with Type 1 Diabetes. The program aims to address critical barriers to delivery of quality T1D care in India by building awareness, improving access to screening, diagnosis, and treatment services, enabling treatment adherence and self-management, and strengthening governance framework for delivery of T1D care.
Position Summary:
WJCF seeks a highly motivated and detail-oriented individual with outstanding credentials and demonstrated analytical and problem-solving abilities for the role of Senior Analyst (Type 1 Diabetes), based in New Delhi. The Sr. Analyst will actively engage and support program implementation work in focus geographies, helping launch new initiatives as well as accelerate ongoing interventions to improve T1D care outcomes. The Analyst will support program implementation at the state level to strengthen data-driven decision-making, generate insights, support implementation, and contribute to the development of high-quality program materials and analyses.
The ideal candidate would bring strong analytical and communication skills, be comfortable working across multiple stakeholders and geographies simultaneously, and carry an ability to synthesize complex programmatic information into clear, actionable outputs. They would be self-driven, intellectually curious, and motivated by the opportunity to inform large-scale public health programs and deliver impact.
Last Date to Apply: 11th July, 2026
Software Powered by iCIMS
www.icims.com